Toki-shakuyaku-san, a Japanese kampo medicine, reduces colon inflammation in a mouse model of acute colitis. 2015

Remya Sreedhar, and Somasundaram Arumugam, and Rajarajan A Thandavarayan, and Vijayasree V Giridharan, and Vengadeshprabhu Karuppagounder, and Vigneshwaran Pitchaimani, and Rejina Afrin, and Meilei Harima, and Takashi Nakamura, and Kazuyuki Ueno, and Masahiko Nakamura, and Kenji Suzuki, and Kenichi Watanabe
Department of Clinical Pharmacology, Faculty of Pharmaceutical Sciences, Niigata University of Pharmacy and Applied Life Sciences, Niigata City 956-8603, Japan.

Toki-shakuyaku-san (TOKI) is a Japanese kampo medicine, which consists of a mixture of herbal medicines and considered to be a promising remedial agent due to its immunomodulatory and anti-inflammatory effects. We examined the beneficial effects of TOKI in inflammatory bowel disease associated with the inflammation of the intestinal barrier. A study was designed, using C57BL/6 female mice and were administered with 3% DSS in drinking water for 8days with or without 1g/kg/day TOKI orally for the last 3days and a normal group supplied with plain drinking water for 8days. TOKI treatment attenuated the clinical symptoms of acute murine colitis and also alleviated the inflammatory mechanism by reducing the inflammatory mediators, such as IL-1β, IL-2, TGF-β, RAGE and TLR2. It has also decreased the levels of CHOP, caspase12, cleaved caspase3 and cleaved caspase7 and thereby down-regulated the endoplasmic reticulum stress and apoptotic signaling induced by DSS. Moreover, the expression levels of cyclin D1 and c-kit have also confirmed the beneficial role of TOKI in colitis. All these data suggested that TOKI can be a promising agent for the treatment of colitis since it alleviates the disease progression and severity.

UI MeSH Term Description Entries
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D003092 Colitis Inflammation of the COLON section of the large intestine (INTESTINE, LARGE), usually with symptoms such as DIARRHEA (often with blood and mucus), ABDOMINAL PAIN, and FEVER. Colitides
D003106 Colon The segment of LARGE INTESTINE between the CECUM and the RECTUM. It includes the ASCENDING COLON; the TRANSVERSE COLON; the DESCENDING COLON; and the SIGMOID COLON. Appendix Epiploica,Taenia Coli,Omental Appendices,Omental Appendix,Appendices, Omental,Appendix, Omental
D004365 Drugs, Chinese Herbal Chinese herbal or plant extracts which are used as drugs to treat diseases or promote general well-being. The concept does not include synthesized compounds manufactured in China. Chinese Herbal Drugs,Plant Extracts, Chinese,Chinese Drugs, Plant,Chinese Plant Extracts,Extracts, Chinese Plant,Herbal Drugs, Chinese
D005260 Female Females
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000894 Anti-Inflammatory Agents, Non-Steroidal Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. Analgesics, Anti-Inflammatory,Aspirin-Like Agent,Aspirin-Like Agents,NSAID,Non-Steroidal Anti-Inflammatory Agent,Non-Steroidal Anti-Inflammatory Agents,Nonsteroidal Anti-Inflammatory Agent,Anti Inflammatory Agents, Nonsteroidal,Antiinflammatory Agents, Non Steroidal,Antiinflammatory Agents, Nonsteroidal,NSAIDs,Nonsteroidal Anti-Inflammatory Agents,Agent, Aspirin-Like,Agent, Non-Steroidal Anti-Inflammatory,Agent, Nonsteroidal Anti-Inflammatory,Anti-Inflammatory Agent, Non-Steroidal,Anti-Inflammatory Agent, Nonsteroidal,Anti-Inflammatory Analgesics,Aspirin Like Agent,Aspirin Like Agents,Non Steroidal Anti Inflammatory Agent,Non Steroidal Anti Inflammatory Agents,Nonsteroidal Anti Inflammatory Agent,Nonsteroidal Anti Inflammatory Agents,Nonsteroidal Antiinflammatory Agents
D015431 Weight Loss Decrease in existing BODY WEIGHT. Weight Reduction,Loss, Weight,Losses, Weight,Reduction, Weight,Reductions, Weight,Weight Losses,Weight Reductions
D016207 Cytokines Non-antibody proteins secreted by inflammatory leukocytes and some non-leukocytic cells, that act as intercellular mediators. They differ from classical hormones in that they are produced by a number of tissue or cell types rather than by specialized glands. They generally act locally in a paracrine or autocrine rather than endocrine manner. Cytokine
D016264 Dextran Sulfate Long-chain polymer of glucose containing 17-20% sulfur. It has been used as an anticoagulant and also has been shown to inhibit the binding of HIV-1 to CD4-POSITIVE T-LYMPHOCYTES. It is commonly used as both an experimental and clinical laboratory reagent and has been investigated for use as an antiviral agent, in the treatment of hypolipidemia, and for the prevention of free radical damage, among other applications. Sodium Dextran Sulfate,Dextran Sulfate Sodium,Dextran Sulfate, Sodium,Sulfate Sodium, Dextran,Sulfate, Dextran,Sulfate, Sodium Dextran

Related Publications

Remya Sreedhar, and Somasundaram Arumugam, and Rajarajan A Thandavarayan, and Vijayasree V Giridharan, and Vengadeshprabhu Karuppagounder, and Vigneshwaran Pitchaimani, and Rejina Afrin, and Meilei Harima, and Takashi Nakamura, and Kazuyuki Ueno, and Masahiko Nakamura, and Kenji Suzuki, and Kenichi Watanabe
August 2007, Psychiatry and clinical neurosciences,
Remya Sreedhar, and Somasundaram Arumugam, and Rajarajan A Thandavarayan, and Vijayasree V Giridharan, and Vengadeshprabhu Karuppagounder, and Vigneshwaran Pitchaimani, and Rejina Afrin, and Meilei Harima, and Takashi Nakamura, and Kazuyuki Ueno, and Masahiko Nakamura, and Kenji Suzuki, and Kenichi Watanabe
March 2003, Journal of pharmacological sciences,
Remya Sreedhar, and Somasundaram Arumugam, and Rajarajan A Thandavarayan, and Vijayasree V Giridharan, and Vengadeshprabhu Karuppagounder, and Vigneshwaran Pitchaimani, and Rejina Afrin, and Meilei Harima, and Takashi Nakamura, and Kazuyuki Ueno, and Masahiko Nakamura, and Kenji Suzuki, and Kenichi Watanabe
January 1989, The American journal of Chinese medicine,
Remya Sreedhar, and Somasundaram Arumugam, and Rajarajan A Thandavarayan, and Vijayasree V Giridharan, and Vengadeshprabhu Karuppagounder, and Vigneshwaran Pitchaimani, and Rejina Afrin, and Meilei Harima, and Takashi Nakamura, and Kazuyuki Ueno, and Masahiko Nakamura, and Kenji Suzuki, and Kenichi Watanabe
January 1996, The American journal of Chinese medicine,
Remya Sreedhar, and Somasundaram Arumugam, and Rajarajan A Thandavarayan, and Vijayasree V Giridharan, and Vengadeshprabhu Karuppagounder, and Vigneshwaran Pitchaimani, and Rejina Afrin, and Meilei Harima, and Takashi Nakamura, and Kazuyuki Ueno, and Masahiko Nakamura, and Kenji Suzuki, and Kenichi Watanabe
January 1998, Methods and findings in experimental and clinical pharmacology,
Remya Sreedhar, and Somasundaram Arumugam, and Rajarajan A Thandavarayan, and Vijayasree V Giridharan, and Vengadeshprabhu Karuppagounder, and Vigneshwaran Pitchaimani, and Rejina Afrin, and Meilei Harima, and Takashi Nakamura, and Kazuyuki Ueno, and Masahiko Nakamura, and Kenji Suzuki, and Kenichi Watanabe
January 1994, Drug metabolism and drug interactions,
Remya Sreedhar, and Somasundaram Arumugam, and Rajarajan A Thandavarayan, and Vijayasree V Giridharan, and Vengadeshprabhu Karuppagounder, and Vigneshwaran Pitchaimani, and Rejina Afrin, and Meilei Harima, and Takashi Nakamura, and Kazuyuki Ueno, and Masahiko Nakamura, and Kenji Suzuki, and Kenichi Watanabe
July 2000, Journal of ethnopharmacology,
Remya Sreedhar, and Somasundaram Arumugam, and Rajarajan A Thandavarayan, and Vijayasree V Giridharan, and Vengadeshprabhu Karuppagounder, and Vigneshwaran Pitchaimani, and Rejina Afrin, and Meilei Harima, and Takashi Nakamura, and Kazuyuki Ueno, and Masahiko Nakamura, and Kenji Suzuki, and Kenichi Watanabe
January 1999, Reproduction, fertility, and development,
Remya Sreedhar, and Somasundaram Arumugam, and Rajarajan A Thandavarayan, and Vijayasree V Giridharan, and Vengadeshprabhu Karuppagounder, and Vigneshwaran Pitchaimani, and Rejina Afrin, and Meilei Harima, and Takashi Nakamura, and Kazuyuki Ueno, and Masahiko Nakamura, and Kenji Suzuki, and Kenichi Watanabe
January 1988, The American journal of Chinese medicine,
Remya Sreedhar, and Somasundaram Arumugam, and Rajarajan A Thandavarayan, and Vijayasree V Giridharan, and Vengadeshprabhu Karuppagounder, and Vigneshwaran Pitchaimani, and Rejina Afrin, and Meilei Harima, and Takashi Nakamura, and Kazuyuki Ueno, and Masahiko Nakamura, and Kenji Suzuki, and Kenichi Watanabe
January 2013, The American journal of Chinese medicine,
Copied contents to your clipboard!